Hot Topics in Pharmacy: ASHP Advantage: New Year, New Subvariants- COVID Therapeutics in 2023

Faculty from our Summer Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.